Abstracts

H/L-FERRITINS AND TIM-1 ASSOCIATED WITH NEUROCOGNITIVE FUNCTION IN PEOPLE WITH HIV

HIV infection and inflammation alter iron homeostasis, which is essential for energy production and brain health. We previously reported that higher cerebrospinal fluid levels of the oligodendrocyte iron-delivery protein ferritin heavy-chain (Fth1) may protect against neurocognitive impairment (NCI) in people with HIV (PWH). Here, we hypothesized that higher serum Fth1 and ferritin light-chain (Ftl) levels,…

CSF EXOSOME A?42 AND TAU/A?42 RATIO ASSOCIATED WITH COGNITIVE DISORDERS IN OLDER PWH

HIV-associated neurocognitive disorders (HAND) remain prevalent despite viral suppression on current antiretroviral therapy (ART). Older people with HIV (PWH) are also at risk for amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD), but biomarkers to distinguish these disorders from HAND are unavailable. ?-amyloid (A?) and Tau are associated with cognitive decline in aMCI/AD, but…

PHARMACOGENETICS OF THE LATE-ONSET EFAVIRENZ NEUROTOXICITY SYNDROME (LENS)

Early-onset neuropsychiatric adverse effects of efavirenz are common and usually mild. The recently-described late-onset efavirenz neurotoxicity syndrome (LENS) presents as severe ataxia and/or encephalopathy, and is associated with supratherapeutic efavirenz plasma concentrations (>4 µg/mL). Efavirenz is primarily metabolized by cytochrome P450 2B6 (CYP2B6), with CYP2A6 as an accessory pathway. We hypothesized that participants with LENS…